Parewijck W, Thiery M, Decoster J M
Z Geburtshilfe Perinatol. 1980 Oct;184(5):366-70.
The use of 15 (S)-15-methyl-prostaglandin F2 alpha for second-trimester termination of pregnancy, induction of labor in the presence of a dead or severely malformed fetus, and the management of molar pregnancy was investigated in 212 women. The dosage regime was 250 microgram of the prostaglandin analogue every 1 to 3 hours. Cumulative expulsion rates amounted to 94 and 97% after 24 to 36 hours, respectively. Gastrointestinal side effects occurred in 48% of the patients, and both the number and intensity of the episodes were significantly reduced by antiemetic and antidiarrheal drugs. No serious complications occurred.
对212名妇女研究了15(S)-15-甲基前列腺素F2α用于中期妊娠终止、死胎或严重畸形胎儿引产以及葡萄胎处理的情况。给药方案是每1至3小时给予250微克前列腺素类似物。24至36小时后的累积排出率分别为94%和97%。48%的患者出现胃肠道副作用,使用止吐药和止泻药后,发作次数和严重程度均显著降低。未发生严重并发症。